Report : Europe Diet Pills Market Forecast to 2028 – Regional Analysis – By Product Type (Prescription, Over the Counter Drugs, and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Children and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)
Appetite Suppression Segment to Dominate Europe Diet Pills Market During 2021–2028
According to a new market research study on “Europe Diet Pills Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, Age Group, Distribution Channel, and Country” is expected to reach US$ 613.38 million by 2028 from US$ 311.90 million in 2021. The market is estimated to grow at a CAGR of 10.1% from 2021 to 2028. The report provides trends prevailing in the Europe diet pills market along with the drivers and restraints pertaining to the market growth. Self-Directed care is widely used and growing issue of obesity are the major factor driving the growth of the Europe diet pills market. However, Regulatory Environment is difficult hinders the growth of Europe diet pills market.
The Europe diet pills market is segmented based on product type, application, age group, distribution channel and country. Based on product type, the Europe diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the Europe diet pills market in 2020. Based on application, the Europe diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment dominated the Europe diet pills market in 2020. Based on age group, Europe diet pills market is segmented into adults, and teenagers. The adults segment dominated the Europe diet pills market in 2020. Based on distribution channel, Europe diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug Stores. The hospital pharmacies segment dominated the Europe Diet Pills market in 2020. Based on country, the Europe diet pills market is segmented into Germany, France, UK, Italy, Spain, and Rest of Europe. The Germany segment dominated the Europe diet pills market in 2020.
Pfizer Inc. (Arena Pharmaceutical GMBH); Novo Nordisk A/S; GlaxoSmithKline plc; Lovate Health Sciences International Inc.; TEVA Pharmaceutical Industries LTD; and Chong’s Health Care; are among the leading companies in the Europe Diet Pills market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Novo Nordisk A/S received US Food and Drug Administration (FDA) approval for Wegovy (the brand name for once-weekly semaglutide 2.4 mg injection in the US) for chronic weight management. The approval was based on the results from the STEP phase 3a clinical trial programme.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com